SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-076278
Filing Date
2023-03-22
Accepted
2023-03-22 07:36:03
Documents
14
Period of Report
2023-03-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d451722d8k.htm   iXBRL 8-K 24616
2 EX-99.1 d451722dex991.htm EX-99.1 107710
6 GRAPHIC g451722g0322114952032.jpg GRAPHIC 6221
  Complete submission text file 0001193125-23-076278.txt   279403

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA wve-20230322.xsd EX-101.SCH 2874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20230322_lab.xml EX-101.LAB 17926
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20230322_pre.xml EX-101.PRE 11254
8 EXTRACTED XBRL INSTANCE DOCUMENT d451722d8k_htm.xml XML 3326
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 23751431
SIC: 2834 Pharmaceutical Preparations